EUVIMEDOpdag EUVIMED
Open access

Second‐order allosteric control as a mechanism for compensatory mutations in B‐cell translocation gene 2

Nicholas J Ose, Paul Campitelli, Tushar Modi, S Banu Ozkan iD

Protein Science · 2025-09 · 34 (9)

DOI: 10.1002/pro.70270 ↗

At a glance

Journal article in Protein Science, published online on 2025-08-25. Written by Nicholas J Ose and 3 co-authors. Institution: Department of Physics and Center for Biological Physics, Arizona State University, Tempe, Arizona, USA. Major MEDLINE topics: Immediate-Early Proteins, Tumor Suppressor Proteins. Cited 5 times so far (Crossref); 116 references. The full text is freely available in PubMed Central. Funded by: NIGMS NIH HHS, Gordon and Betty Moore Foundation, NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The mechanism underlying the pathogenic impact of mutations within intrinsically disordered regions of proteins remains enigmatic, and the mechanisms behind compensatory responses to these perturbations lie within an even deeper veil of obscurity. This study focuses on the compensatory mechanisms of single nucleotide variants within the disordered C‐terminal tail of the BTG2 protein, a crucial regulator in cell cycle control. Here, we develop a novel approach by combining molecular dynamics simulations with time‐dependent linear response theory to accurately compute the long‐distance coupling dynamics between the tail and the structured domain. Using this approach, we reveal how specific mutations can counteract the functional disruptions caused by a known disease‐associated mutation, V141M. Our findings demonstrate that the disordered tail regulates critical binding sites allosterically, and a weakening of this modulation may contribute to disease manifestation. However, compensatory mutations restore lost interactions between the disordered region and binding sites, exerting long‐distance dynamic control over both critical binding sites and the mutation site 141M. This secondhand allosteric control could be a general mechanism for compensatory mutations to rescue function. These insights not only illuminate the pathogenic mechanisms at play but also offer a framework for identifying potential therapeutic targets in diseases associated with disordered protein regions.

Subjects

MeSH terms (MEDLINE)

Immediate-Early ProteinsTumor Suppressor ProteinsMolecular Dynamics SimulationAllosteric RegulationHumansMutationBinding Sites

Author keywords

allosteryintrinsically disordered regionslinear response theorymolecular dynamics simulationsprotein dynamics

Substances

Immediate-Early ProteinsTumor Suppressor ProteinsBTG2 protein, human

Authors and institutions

  • Department of Physics and Center for Biological Physics, Arizona State University, Tempe, Arizona, USA.

ORCID profiles: S Banu Ozkan

Funding

  • NIGMS NIH HHS
  • Gordon and Betty Moore Foundation
  • NIH HHS
  • National Institutes of Health

Cite

APA

Ose, N. J., Campitelli, P., Modi, T., & Ozkan, S. B. (2025). Second‐order allosteric control as a mechanism for compensatory mutations in B‐cell translocation gene 2. Protein Science, 34(9). https://doi.org/10.1002/pro.70270

Vancouver

Ose NJ, Campitelli P, Modi T, Ozkan SB. Second‐order allosteric control as a mechanism for compensatory mutations in B‐cell translocation gene 2. Protein Science. 2025;34(9). doi:10.1002/pro.70270

BibTeX
@article{Ose2025,
  author = {Ose, Nicholas J and Campitelli, Paul and Modi, Tushar and Ozkan, S Banu},
  title = {Second‐order allosteric control as a mechanism for compensatory mutations in B‐cell translocation gene 2},
  journal = {Protein Science},
  year = {2025},
  volume = {34},
  number = {9},
  doi = {10.1002/pro.70270}
}
Start for free →